Polio eradication in the African Region on course despite public health emergencies

被引:12
作者
Okeibunor, Joseph C. [1 ]
Ota, Martin C. [2 ]
Akanmori, Bartholomew D. [3 ]
Gumede, Nicksy [1 ]
Shaba, Keith [1 ]
Kouadio, Koffi I. [1 ]
Poy, Alain [1 ]
Mihigo, Richard [3 ]
Salta, Mbaye [1 ]
Moeti, Matshidiso R. [4 ]
机构
[1] WHO AFRO, Polio Eradicat Programme, Reg Directors Off, Brazzaville, Rep Congo
[2] WHO AFRO, Hlth Syst & Serv, Brazzaville, Rep Congo
[3] WHO AFRO, Immunizat & Vaccine Preventable Dis Mbaye, Brazzaville, Rep Congo
[4] WHO AFRO, Reg Directors Off, Brazzaville, Rep Congo
关键词
Polio eradication; Polioviruses; WHO African Region; IPV; bOPV; tOPV; vaccines; POLIOMYELITIS; NAMIBIA;
D O I
10.1016/j.vaccine.2015.08.024
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The World Health Organization, African Region is heading toward eradication of the three types of wild polio virus, from the Region. Cases of wild poliovirus (WPV) types 2 and 3 (WPV2 and WPV3) were last reported in 1998 and 2012, respectively, and WPV1 reported in Nigeria since July 2014 has been the last in the entire Region. This scenario in Nigeria, the only endemic country, marks a remarkable progress. This significant progress is as a result of commitment of key partners in providing the much needed resources, better implementation of strategies, accountability, and innovative approaches. This is taking place in the face of public emergencies and challenges, which overburden health systems of countries and threaten sustainability of health programmes. Outbreak of Ebola and other diseases, insecurity, civil strife and political instability led to displacement of populations and severely affected health service delivery. The goal of eradication is now within reach more than ever before and countries of the region should not relent in their efforts on polio eradication. WHO and partners will redouble their efforts and introduce better approaches to sustain the current momentum and to complete the job. The carefully planned withdrawal of oral polio vaccine type II (OPV2) with an earlier introduction of one dose of inactivated poliovirus vaccine (IPV), in routine immunization, will boost immunity of populations and stop cVDPVs. Environmental surveillance for polio viruses will supplement surveillance for AFP and improve sensitivity of detection of polio viruses. (C) 2016 World Health Organization. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1202 / 1206
页数:5
相关论文
共 19 条
  • [1] [Anonymous], 2006, Wkly Epidemiol Rec, V81, P63
  • [2] [Anonymous], 2013, WHO VACC PREV DIS MO
  • [3] Polio outbreaks in Namibia, 1993-1995: Lessons learned
    Biellik, RJ
    Allies, T
    Woodfill, CJI
    Lobanov, A
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 175 : S30 - S36
  • [4] POLIOMYELITIS IN NAMIBIA
    BIELLIK, RJ
    LOBANOV, A
    HEATH, K
    REICHLER, M
    TJAPEPUA, V
    ALLIES, T
    VANNIEKERK, ABW
    SCHOUB, BD
    [J]. LANCET, 1994, 344 (8939-4) : 1776 - 1776
  • [5] Chandrakant L., 2007, B WORLD HEALTH ORGAN, V85, P487
  • [6] Closser S, 2014, J INFECT DIS
  • [7] Expanded Programme on Immunization, 1996, USITC PUBL, VWHO/EPVCEIS/96.01
  • [8] Global Polio Eradication Initiative, 2006, MONTHL SIT REP
  • [9] PARALYTIC POLIOMYELITIS - SEASONED STRATEGIES, DISAPPEARING DISEASE
    HULL, HF
    WARD, NA
    HULL, BP
    MILSTIEN, JB
    DEQUADROS, C
    [J]. LANCET, 1994, 343 (8909) : 1331 - 1337
  • [10] Poliomyelitis in Angola: Current status and implications for poliovirus eradication in southern Africa
    Izurieta, HS
    Biellik, RJ
    Kew, OM
    Valente, FL
    Chezzi, C
    Sutter, RW
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 175 : S24 - S29